NAFDAC DG, Prof. Mojisola Adeyeye
NAFDAC Bans Turkey-Made Dex Luxury Bar Soap, Alerts Public on Counterfeit Indian Injection Powder
The National Agency for Food and Drug Administration and Control (NAFDAC) has enforced a ban on the sale of Dex Luxury Bar Soap manufactured in Turkey. This decision comes in response to findings that the soap contains Butyphenyl Methylpropional, a substance prohibited in cosmetic products due to its potential harm to reproductive health and skin sensitization. Notably, the product lacks compliance with the Cosmetic Products Regulation and has faced bans in certain European jurisdictions.
While the soap is not listed in NAFDAC’s database, the agency urges caution among importers, distributors, retailers, and consumers, advising them to scrutinize product authenticity and cease its sale or use. Any suspected adverse reactions or instances of substandard products should be reported to NAFDAC promptly.
Additionally, NAFDAC raises awareness regarding counterfeit Tandak injection powder from India, recently discovered in Gombe State. The agency emphasizes the differences between the authentic and counterfeit versions, including variations in batch numbers, manufacturing dates, and packaging features. Healthcare professionals and consumers are urged to exercise vigilance and report any suspicions or adverse effects related to medicinal products.
NAFDAC underscores the importance of sourcing medical products from authorized suppliers and encourages the use of reporting platforms for any concerns regarding counterfeit or substandard products. Vigilance within the supply chain is paramount to prevent the distribution and use of counterfeit goods, ensuring public safety and health.
